J
John P. Boehmer
Researcher at Penn State Milton S. Hershey Medical Center
Publications - 162
Citations - 16317
John P. Boehmer is an academic researcher from Penn State Milton S. Hershey Medical Center. The author has contributed to research in topics: Heart failure & Cardiac resynchronization therapy. The author has an hindex of 42, co-authored 145 publications receiving 15087 citations. Previous affiliations of John P. Boehmer include University of Alabama at Birmingham & Rush University Medical Center.
Papers
More filters
Journal ArticleDOI
Echocardiographic findings in Fulminant and acute myocarditis
G. Michael Felker,John P. Boehmer,Ralph H. Hruban,Grover M. Hutchins,Edward K. Kasper,Kenneth L. Baughman,Joshua M. Hare +6 more
TL;DR: Echocardiography has value in classifying patients with myocarditis and may provide prognostic information and patients with fulminantMyocarditis exhibit a substantial improvement in ventricular function at six months compared with those with acute Myocarditis.
Journal ArticleDOI
Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival
David L. Hayes,John P. Boehmer,John D. Day,F.R. Gilliam,Paul A. Heidenreich,Milan Seth,Paul W. Jones,Leslie A. Saxon +7 more
TL;DR: Every effort should be made to reduce native atrioventricular conduction with cardiac resynchronization therapy systems in an attempt to achieve biventricular pacing as close to 100% as possible.
Journal ArticleDOI
Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial
Leslie A. Saxon,Michael R. Bristow,John P. Boehmer,Steven K. Krueger,David A. Kass,Teresa De Marco,Peter E. Carson,Lorenzo DiCarlo,Arthur M. Feldman,Elizabeth Galle,Fred Ecklund +10 more
TL;DR: In CRT candidates, sudden cardiac death risk is associated with higher New York Heart Association class and renal dysfunction and in CRT-defibrillator recipients, reduction in the risk of an appropriate shock is associatedWith medical therapy with neurohormonal antagonists, female gender, and New York heart Association functional class III versus IV clinical status.
Journal ArticleDOI
A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study
John P. Boehmer,Ramesh Hariharan,Fausto G. Devecchi,Andrew L. Smith,Giulio Molon,Alessandro Capucci,Qi An,Viktoria A. Averina,Craig Stolen,Pramodsingh H. Thakur,Julie A. Thompson,Ramesh Wariar,Yi Zhang,Jagmeet P. Singh +13 more
TL;DR: The HeartLogic multisensor index and alert algorithm provides a sensitive and timely predictor of impending HF decompensation.
Journal ArticleDOI
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure Analysis From the Sudden Cardiac Death in Heart Failure Trial
Douglas L. Packer,Jordan M. Prutkin,Anne S. Hellkamp,L. Brent Mitchell,Robert C. Bernstein,Freda Wood,John P. Boehmer,Mark D. Carlson,Robert P. Frantz,Steve E. McNulty,Joseph G. Rogers,Jill Anderson,George Johnson,Mary Norine Walsh,Jeanne E. Poole,Daniel B. Mark,Kerry L. Lee,Gust H. Bardy +17 more
TL;DR: ICD therapy reduced cardiac mortality and sudden death presumed to be ventricular tachyarrhythmic in SCD-HeFT and had no effect on heart failure mortality.